Cytokinetics, Incorporated · NASDAQ:CYTK
Cytokinetics, Incorporated shareholders
As of Sep 30, 2026, 458 institutions reported holding Cytokinetics, Incorporated. Largest: BlackRock, T. Rowe Price and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cytokinetics, Incorporated | Change | Filed |
|---|---|---|---|---|
| BlackRock | 21M | +947K | Nov 13, 2026 | |
| T. Rowe Price | 20.5M | −184K | Nov 16, 2026 | |
| Vanguard | 14.2M | +273K | Nov 16, 2026 | |
| Wellington | 10.6M | +3.66M | Nov 16, 2026 | |
| Polar Capital Holdings Plc | 9.64M | +7.38M | Nov 16, 2026 | |
| State Street | 7.14M | +649K | Nov 12, 2026 | |
| Avoro Capital Advisors LLC | 4.9M | −99,999 | Nov 16, 2026 | |
| Bank of America | 4.74M | +99,619 | Nov 16, 2026 | |
| Geode Capital | 3.77M | +55,363 | Nov 6, 2026 | |
| Invesco | 3.02M | +1.78M | Nov 12, 2026 |